Inverse Relationship between PSA and IL-8 in Prostate Cancer: An Insight into a NF-κB-Mediated Mechanism

Screening, risk assessment, and the approach to therapy in patients with prostate cancer

(2010) Stephen J. Freedland   CANCER

RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor- B Alternative Pathway in Tumorigenicity

(2009) Y. Xu et al.   CANCER RESEARCH

Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer

(2009) K. E. Knudsen et al.   CLINICAL CANCER RESEARCH

Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe

(2009) B. B. Aggarwal et al.   CLINICAL CANCER RESEARCH

Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs

(2009) Rajendra K Singh et al.   Molecular Cancer

NF- B as a Critical Link Between Inflammation and Cancer

(2009) M. Karin   Cold Spring Harbor Perspectives in Biology

Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence

(2008) D. J. Caruso et al.   CLINICAL CANCER RESEARCH

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

SN52, a novel nuclear factor- B inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation

(2008) Y. Xu et al.   MOLECULAR CANCER THERAPEUTICS